The influence of lobeline on nucleus accumbens dopamine and locomotor responses to nicotine in nicotine-pretreated rats

British Journal of Pharmacology

Volumn 125, Issue 6, 1998, Pages 1115-1119

  Benwell, Maureen E M ^a   Balfour, David J K ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Lobeline; Locomotion; Microdialysis; Nicotine; Nucleus accumbens

Indexed keywords

DIHYDROXYPHENYLACETIC ACID; DOPAMINE; GANGLION STIMULATING AGENT; LOBELINE; NICOTINE; NICOTINIC RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN; CONTROLLED STUDY; DOSE RESPONSE; INTRAPERITONEAL DRUG ADMINISTRATION; LIMBIC SYSTEM; LOCOMOTION; MALE; MICRODIALYSIS; NONHUMAN; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0031796679     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0702161     Document Type: Article

References (45)

1. 3H]methylcarbamylcholine in rat brain. Eur. J. Pharmacol., 253, 261-267.
2. BALFOUR, D.J.K. & BENWELL, M.E.M. (1993). The role of brain dopamine systems in the psychopharmacological responses to nicotine. Asian Pacific J. Pharmacol., 8, 153-167.
3. BALFOUR, D.J.K., BENWELL, M.E.M. & BIRRELL, C.E (1997). Sensitisation of the mesoaccumbens dopamine response to nicotine. Pharmacol. Biochem Behav., 59, 1021-1030.
4. BALFOUR, D.J.K, BIRRELL, C.E., MORAN, R.J. & BENWELL, M.E.M. (1996). Effects of acute D-CPPene on mesoaccumbens dopamine responses to nicotine in the rat. Eur. J. Pharmacol., 316, 153-156.
5. BENWELL, M.E.M. & BALFOUR, D.J.K. (1992). The effects of acute and repeated nicotine treatment on nucleus accumbens dopamine and locomotor activity. Br. J. Pharmacol., 105, 849-856.
6. BENWELL, M.E.M., BALFOUR, D.J.K. & BIRRELL, C.E (1995). Desensitisation of the nicotine-induced mesolimbic dopamine responses during constant infusion with nicotine. Br. J. Pharmacol., 114, 454-460.
7. BENWELL, M.E.M., BALFOUR, D.J.K. & LUCCHI, H.M. (1993). Influence of tetrodotoxin and calcium on changes in extracellular dopamine levels evoked by systemic nicotine. Psychopharmacology, 112, 467-474.
8. BENWELL, M.E.M., HOLTOM, P.E., MORAN, R.J & BALFOUR, D.J.K. (1996). Neurochemical and behavioural interactions between ibogaine and nicotine in the rat. Br. J. Pharmacol., 117, 743-749.
9. BIRRELL, C.E. & BALFOUR, D.J.K. (1998). The influence of nicotine pretreatment on mesoaccumbens dopamine overflow and locomotor responses to D-amphetamine, Psychopharmacology, in press.
10. BRIONI, J.D., O'NEILL, A.B., KIM, D.J.B. & DECKER, M.W. (1993). Nicotinic receptor agonists exhibit anxiolytic-like effects on the elevated plus-maze. Eur. J. Pharmacol., 238, 1-8.
11. CLARKE, P.B.S., FU, D.S., JAKUBOVIC, A & FIBIGER, H.C. (1988). Evidence that mesolimbic activation underlies the locomotor stimulant action of nicotine in rats. J. Pharmacol. Exp. Ther., 246, 701-708.
12. CLARKE, P.B.S. & PERT, A. (1985). Autoradiographic evidence for nicotinic AChRs on nigrostriatal and mesolimbic dopamine neurones. Brain Res., 348, 355-358.
13. 3H]-dopamine release. Br. J. Pharmacol., 117, 595-606.
14. CORRIGALL, W.A., COEN, K.M. & ADAMSON, K.L. (1994). Self-administered nicotine activates the mesolimbic dopamine system through the ventral tegmental area. Brain Res., 653, 278-284.
15. CORRIGALL, W.A., FRANKLIN, K.B.J., COEN, K.M. & CLARKE, P.B.S. (1992). The mesolimbic dopaminergic system is implicated in the reinforcing effects of nicotine. J. Psychopharmacology., 107, 285-289.
16. DAMAJ, M.I., PATRICK, G.S., CREASEY, K.R. & MARTIN, B.R. (1997). Pharmacology of lobeline, a nicotinic AChR ligand. J Pharmacol. Exp. Ther., 282, 410-419.
17. DECKER, M.W., BRIONI, J.D., BANNON, A.W. & ARNERIC, S.P. (1995). Diversity of neuronal nicotinic acetylcholine receptors: lessons from behaviour and implications for CNS therapeutics. Life Sci., 56, 545-570.
18. DECKER, M.W., MAJCHRZAK, M.J. & ARNERIC, S.P. (1993). Effects of lobeline, a nicotinic AChR agonist, on learning and memory. Pharmacol. Biochem. Behav., 45, 571-576.
19. DONNY, E.C., CAGGIULA, A.R., KNOPF, S. & BROWN, C. (1995). Nicotine self-administration in rats. Psychopharmacology, 122, 390-394.
20. FUDALA, P.J. & IWAMOTO, E.T. (1986). Further studies on nicotine-induced conditioned place preference in the rat. Pharmacol. Biochem. Behav., 25, 1041-1049.
21. HARMANN, S.R. & MARTIN, W.R. (1994). Hyperalgesic and analgesic actions of morphine, U50-488, naltrexone and (-)lobeline in the rat brainstem. Pharmacol. Biochem. Behav., 47, 197-201.
22. HEIMER, L., ZAHM, D.S., CHURCHILL, L., KALIVAS, P.W. & WOHLTMAN, C. (1991). Specificity in the projection patterns of accumbal core and shell in the rat. Neuroscience, 41, 89-125.
23. IMPERATO, A., MULAS, A. & DI CHIARA, G. (1986). Nicotine preferentially stimulated dopamine release in the limbic system of freely moving rats. Eur. J. Pharmacol., 132, 337-338.
24. JARAMILLO, J. & VOLLE, R.L. (1968). A comparison of the ganglionic stimulating and blocking properties of some nicotinic drugs. Arch Int. Pharmacodyn. Ther., 174, 88-97.
25. LAMBERT, J.J., DURANT, N..N. & HENDERSON, E.G. (1983). Drug-induced modification of ionic conductance at the neuromuscular junction. Ann. Rev. Pharmacol. Toxicol., 23, 505-539.
26. 3H]-5-HT from rat hippocampal slices. Neuropharmacology, 35, 1769-1777.
27. NISSELL, M., NOMIKOS, G.G. & SWENSSON, T.H. (1994). Systemic nicotine-induced dopamine release in the rat nucleus accumbens is regulated by nicotinic AChRs in the ventral tegmental area. Synapse, 16, 36-44.
28. NOONEY, J.M., PETERS, J.P. & LAMBERT, J.J. (1992). A patch clamp study of the nicotinic acetylcholine receptor of bovine adrenomedullary chromaffin cells in culture. J. Physiol., 455, 503-527.
29. NUNN-THOMPSON, C.L. & SIMON, P.A. (1989). Pharmacotherapy for smoking cessation. Clin. Pharmacol., 8, 710-720.
30. OLIN, B.R., HEBEL, S.K., GREMP, J.L. & HULBERT, M.K. (1995). Smoking deterrents. In Drug Facts and Comparisons, eds. Olin. B.R. Hebel, S.K., Gremp, J.L. & Hulbert, M.K. pp. 3087-3095. St Louis: J.B. Lippincott Co.
31. PATRICK, J., SEQUELA, P., VERNIINO, S., AMADOR, M., LUETJE, C. & DANI, J.A. (1993). Functional diversity of neuronal nicotinic acetylcholine receptors. Prog. Brain Res., 98, 113-120.
32. PAXINOS, G. & WATSON, C. (1986). The rat brain in stereotaxic coordinates. 2nd edn. Academic Press, Sydney.
33. PIDOPLICHKO, V.I., DE BIAS, M., WILLIAMS, J.T. & DANI, J.A. (1997). Nicotine activates and desensitises midbrain dopamine neurones. Nature, 390, 401-404.
34. 3H]-nicotine to rat brain membranes and its inhibition by analogues of nicotine. Neuropharmacology, 27, 235-241.
35. REAVILL, C., WALTHER, B. STOLERMAN, I.P. & TESTA, B. (1990). Behavioural and pharmacokinetic studies on nicotine, cytisine and lobeline. Neuropharmacology, 29, 619-624.
36. ROCHFORD, J., SEN, A.P. & QUIRION, R. (1996). Effect of nicotine and nicotinic AChR agonists on latent inhibition in the rat. J. Pharmacol. Expt. Ther., 277, 1267-1275.
37. SERSHEN, H., BALLA, A., LAJTHA, A. & VIZI, E.S. (1997). Characterisation of nicotinic AChRs involved in the release of noradrenaline from the hippocampus. Neurosci., 77, 121-130.
38. SHOAIB, M., BENWELL, M.E.M., AKBAR, M.T., STOLERMAN, I.P. & BALFOUR, D.J.K. (1994). Behavioural and neurochemical adaptations to nicotine in rats: influence of NMDA antagonists. Br. J. Pharmacol., 111, 1073-1080.
39. SINGER, G., WALLACE, M & HALL, R. (1982). The effects of dopaminergic nucleus accumbens lesions on the acquisition of schedule-induced self-injection of nicotine in the rat. Pharmacol. Biochem. Behav., 17, 579-581.
40. STOLERMAN, I.P., GARCHA, H.S. & MIRZA, N.R. (1995). Dissociations between the locomotor stimulant and depressant effects of nicotinic agonists in rats. Psychopharmacology, 117, 430-437.
41. STOLERMAN, I.P. & REAVILL, C. (1989). Primary cholinergic and direct dopaminergic mediation of behavioural effects of nicotine. Prog. Brain Res., 79, 227-237.
42. 3H]-dopamine uptake. J. Pharmacol. Exp. Ther., 280, 1432-1444.
43. TURCHI, J., HOLLEY, L.A. & SARTER, M. (1995). Effects of nicotinic acetylcholine receptor ligands on behavioural vigilance in rats. Psychopharmacology, 118, 195-205.
44. VALE, A.L. & BALFOUR, D.J.K. (1989). Aversive environmental stimuli as a factor in the psychostimulant response to nicotine. Pharmacol. Biochem. Behav., 32, 857-860.
45. VEZINA, P., HERVE, D., GLOWINSKI, J. & TASSIN, J.P. (1994). Injections of 6-hydroxydopamine into the ventral tegmental area destroy mesolimbic dopamine neurons but spare the locomotor activating effects of nicotine in the rat. Neurosci. Lett., 168, 111-114.